Technical Analysis for EDIT - Editas Medicine, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 5.32 | 1.92% | 0.10 |
EDIT closed up 1.92 percent on Friday, April 26, 2024, on 68 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 3
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 1.92% | |
| Hammer Candlestick | Bullish | 1.92% | |
| NR7 | Range Contraction | 1.92% | |
| Narrow Range Bar | Range Contraction | 1.92% | |
| New 52 Week Low | Weakness | 1.92% | |
| Wide Bands | Range Expansion | 1.92% | |
| Down 3 Days in a Row | Weakness | 1.92% |
| Alert | Time |
|---|---|
| Up 3% | about 23 hours ago |
| Up 2% | about 23 hours ago |
| Hammer Candlestick Entry | about 23 hours ago |
| Rose Above Previous Day's High | about 23 hours ago |
| Down 1% | about 23 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/03/2024
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Genetics Enzymes Genetic Engineering Genome DNA CRISPR Genome Editing Cas9
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Genetics Enzymes Genetic Engineering Genome DNA CRISPR Genome Editing Cas9
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.9 |
| 52 Week Low | 5.11 |
| Average Volume | 1,991,950 |
| 200-Day Moving Average | 8.32 |
| 50-Day Moving Average | 7.53 |
| 20-Day Moving Average | 6.16 |
| 10-Day Moving Average | 5.55 |
| Average True Range | 0.37 |
| RSI (14) | 25.93 |
| ADX | 34.91 |
| +DI | 13.95 |
| -DI | 33.08 |
| Chandelier Exit (Long, 3 ATRs) | 6.43 |
| Chandelier Exit (Short, 3 ATRs) | 6.21 |
| Upper Bollinger Bands | 7.48 |
| Lower Bollinger Band | 4.84 |
| Percent B (%b) | 0.18 |
| BandWidth | 42.81 |
| MACD Line | -0.64 |
| MACD Signal Line | -0.61 |
| MACD Histogram | -0.0321 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.72 | ||||
| Resistance 3 (R3) | 5.70 | 5.55 | 5.65 | ||
| Resistance 2 (R2) | 5.55 | 5.45 | 5.56 | 5.63 | |
| Resistance 1 (R1) | 5.43 | 5.38 | 5.49 | 5.45 | 5.61 |
| Pivot Point | 5.28 | 5.28 | 5.31 | 5.29 | 5.28 |
| Support 1 (S1) | 5.17 | 5.18 | 5.22 | 5.19 | 5.03 |
| Support 2 (S2) | 5.02 | 5.12 | 5.03 | 5.01 | |
| Support 3 (S3) | 4.90 | 5.02 | 4.99 | ||
| Support 4 (S4) | 4.92 |
